# Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy

> **NCT01895400** · PHASE3 · TERMINATED · sponsor: **Jong Woo Chung** · enrollment: 26 (actual)

## Conditions studied

- Recurrent Vestibulopathy

## Interventions

- **DRUG:** Renexin (cilostazol 100mg + gingko biloba extract 80 mg)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01895400
- **Lead sponsor:** Jong Woo Chung
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Participant enrollment is much delayed. The whole design needs to be revised.
- **Last updated:** 2016-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01895400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01895400, "Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01895400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*